TPO and Thrombocytopenia: Following the purification of Tpo in the mid-1990s, recombinant human Tpo (rhTpo) and a similar protein, megakaryocyte growth and development factor, were extensively tested for their ability to overcome thrombocytopenia, and were shown to significantly increase circulating platelet levels in mice, primates, and humans [7,11–15].